Cocrystal Pharma (COCP) Gross Margin (2010 - 2013)
Cocrystal Pharma (COCP) posted Gross Margin of 28.21% for Q2 2013, down 3.35% sequentially from 29.18% in Q1 2013, and down 1313.0% YoY from 2.33% in Q2 2012.
Cocrystal Pharma (COCP) Gross Margin (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Gross Margin for 4 years, with the latest figure at 28.21% in Q2 2013.
- Quarterly Gross Margin fell 1313.0% year-over-year to 28.21% in Q2 2013, while the trailing twelve-month figure through Jun 2013 was 38.34% (up 1013.0% YoY) and the FY2012 annual result came in at 42.01%, up 2070.0% from the prior year.
- Gross Margin fell to 28.21% in Q2 2013 per COCP's latest filing, from 29.18% in the prior quarter.
- Over five years, Gross Margin peaked at 53.06% in Q3 2011 and troughed at 28.42% in Q4 2011.
- A 4-year average of 35.43% and a median of 41.33% in 2012 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2011 and 2012: Gross Margin slumped 5871 bps in 2011, then jumped 7290 bps in 2012.
- Over 4 years, Gross Margin stood at 30.29% in 2010, then slumped by 194 bps to 28.42% in 2011, then soared by 256 bps to 44.48% in 2012, then sank by 37 bps to 28.21% in 2013.
- According to Business Quant data, Gross Margin over the past three periods registered 28.21%, 29.18%, and 44.48% for Q2 2013, Q1 2013, and Q4 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 28.21% |
| Mar 31, 2013 | 29.18% |
| Dec 31, 2012 | 44.48% |
| Sep 30, 2012 | 41.33% |
| Jun 30, 2012 | 41.34% |
| Mar 31, 2012 | 41.17% |
| Dec 31, 2011 | -28.42% |
| Sep 30, 2011 | 53.06% |
| Jun 30, 2011 | 34.35% |
| Mar 31, 2011 | 46.40% |
| Dec 31, 2010 | 30.29% |
| Sep 30, 2010 | 46.85% |
| Jun 30, 2010 | 52.39% |